Latest financial market updates and expert analysis
AI & Quantum Computing In a clear statement of strategic direction, Netflix has opted against a blockbuster acquisition in favor of a targeted technology investment. The streaming leader has agreed to a performance-linked deal...
Viking Therapeutics has progressed its obesity treatment program, centered on the drug candidate VK2735, into the pivotal Phase 3 stage...
The global pivot toward energy security is casting a powerful spotlight on NAC Kazatomprom, the world’s largest uranium producer. European...
The performance of Armour Residential REIT is currently navigating a market landscape dominated by expectations surrounding the U.S. Federal Reserve’s...
The narrative surrounding hydrogen technology firm Plug Power has long been dominated by significant losses and unmet targets. However, recent...
Biotechnology firm Scholar Rock is poised to make a significant strategic shift from a development-stage company to a commercial entity....
Ultragenyx Pharmaceutical has reported significant progress in its clinical development for a rare genetic disorder. New data from a Phase...
The lidar technology firm Microvision is navigating a critical strategic shift. Having focused on research for years, the company is...
The biopharmaceutical firm Axsome Therapeutics is executing an aggressive growth strategy centered on commercial expansion and a rich development pipeline....
While The Trade Desk closed its last fiscal year with a solid increase in profit, the advertising technology specialist is...
Wall Street’s attention has turned to biotech firm Ocugen as it advances its gene therapy programs for inherited retinal diseases....
